SecProbe.io

CORRESP
1
filename1.htm

Top KingWin Limited

Room 1304, Building No. 25, Tian’an
Headquarters Center,

No. 555 North Panyu Avenue, Donghuan
Street

Panyu District, Guangzhou, Guangdong Province,
China

January 14, 2025

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Trade & Services

100 F Street, N.E.

Washington, D.C. 20549

    Attn:
    Rucha Pandit and Dietrich King

    Re:
    Top KingWin Ltd

    Registration Statement on Form F-3 Filed November 6, 2024

    File No. 333-283030

Dear Rucha Pandit and Dietrich King:

Top KingWin Limited (the
“Company”, “WAI,” “we”, “us” or “our”)
hereby provide a response to the comments issued in a letter dated January 6, 2025 (the “Staff’s Letter”) regarding
the Company’s Form F-3 originally filed on November 6, 2024 (the “F-3”). Contemporaneously, we are filing an
amendment to the F-3 via Edgar (the “Amendment No. 2”).

In order to facilitate
the review by the staff of the Securities and Exchange Commission (the “Staff”) of the Amendment No. 2, we have
responded to the comments set forth in the Staff’s Letter on a point-by-point basis. The numbered paragraphs set forth below
respond to the Staff’s comments and correspond to the numbered paragraph in the Staff’s Letter.

Amendment No. 1 to Registration Statement
on Form F-3

Cover Page

1. We
note your revised disclosure in response to prior comment 3 and reissue it in part. In this regard, we note that “Top KingWin Ltd
(“Top KingWin,” the “Company,” “we,” or “us”) is a holding company incorporated under
the laws of Cayman Islands.” However, we also note that pages ii and iii indicate that references to ““we,” “us,”
“our company,” “our,” the “Company” and “Top KingWin” refer to Top KingWin Ltd, a Cayman
Islands company, and its subsidiaries (emphasis added).” Please revise the prospectus to consistently disclose how you will refer
to the holding company and subsidiaries.

Response: In response
to the Staff’s comment, we amended the language on pages ii and iii to clarify that “we,” “us,” “our
company,” “our,” the “Company” and “Top KingWin” refer to Top KingWin Ltd, a Cayman Islands
company; except that when describing the consolidated financial information, definitions of such terms also include the Company’s
subsidiaries.

2. We
note your response to prior comment 6 and reissue it. Please amend your disclosure here and in the summary of risk factors section to
clearly state that, to the extent cash or assets in the business is in the PRC/Hong Kong or a PRC/Hong Kong entity, the funds or assets
may not be available to fund operations or for other use outside of the PRC/Hong Kong due to interventions in or the imposition of restrictions
and limitations on the ability of you or your subsidiaries by the PRC government to transfer cash or assets. On the cover page, provide
cross-references to these other discussions in the summary of risk factors and risk factors sections.

Response: In response
to the Staff’s comment, we amended the disclosure on the prospectus cover page and Summary of Risk Factors on page 7 of the prospectus
and added a cross-reference to the pertinent risk factor disclosed in the Form 20-F for the fiscal year ending December 31, 2023, filed
on April 30, 2024.

3. We
note your revised disclosure in response to prior comment 7 and reissue it in part. In this regard, we note your representations that
you “may encounter difficulties in our ability to transfer cash within our organization in the future” and that “the relevant
laws and regulations in China do not impose limitations on the amount of funds that we can transfer out of China.” Please revise
your disclosure here and elsewhere as appropriate to more clearly discuss whether there are limitations on your ability to transfer cash
between you, your subsidiaries or investors.

Response: In response
to the Staff’s comment, we amended the disclosure on the prospectus cover page and in the Prospectus Summary on page 5 of the prospectus.

Permissions and Approvals from the PRC Authorities,
page 3

4. We
note your disclosure that “[a]s of the date of this prospectus, we and our PRC operating entities have received from PRC authorities
all requisite licenses, including business licenses, permissions, and approvals needed to engage in the businesses currently conducted
in the PRC, and no such permission or approval has been denied.” Please revise to explain how you arrived at this conclusion and
the basis for your conclusion.

Response:
In response to the Staff’s comment, we amended the disclosure on page 3 of the prospectus.

Prospectus Summary

Business Overview, page 5

5. We
note your response to comment 10 and reissue it. Please revise this section to clearly disclose that the company uses a structure that
involves subsidiaries in Hong Kong and China and what that entails. Describe how this type of corporate structure may affect investors
and the value of their investment, including how and why it may be less effective than direct ownership. Additionally, please identify
the entity (including the domicile) in which investors are purchasing their interest and the entity(ies) in which the company’s operations
are conducted. Lastly, please revise the diagram of the company’s organizational structure on page 2 to identify the shareholders who
are affiliates and their percentage shareholdings in Top KingWin Ltd, as well as the aggregate holdings of the non-affiliated shareholders.

Response: In response
to the Staff’s comment, we amended our disclosure in the Business Overview on page 5 of the prospectus and updated the organizational
structure chart on page 6 of the prospectus.

Summary of Risk Factors

Risks Related to Doing Business in China,
page 6

6. We
note your revised disclosure in response to prior comment 11 and reissue it in part. Please revise to clearly identify the risk that the
Chinese government may intervene or influence your operations at any time, or may exert more control over offerings conducted overseas
and/or foreign investment in China-based issuers, which could result in a material change in your operations and/or the value of the securities
you are registering for sale. Lastly, please ensure that each summary risk factor related to your operations in China is accompanied
by a cross-reference (title and page) to the relevant individual detailed risk factor.

Response: In response
to the Staff’s comment, we amended our disclosure in the Summary of Risk Factors on page 7 and in the Risk Factors section on page
10 of the prospectus, by consolidating two pertinent risk factors into one.

    2

General

7. We note your disclosure here and throughout the prospectus that
you have been “advised by [y]our PRC counsel” regarding various regulatory permissions and approvals. Please clarify whether
relying on counsel’s “advice” is the same as relying on counsel’s “opinion.” If so, please revise in all applicable
areas to specifically state that the company has relied on the opinion of counsel.

Response: In response to the Staff’s
comment, we have revised the language of “[a]s advised by our PRC counsel” throughout this Amendment to “according to
the opinion of our PRC counsel.”

For any further comments,
please reach out to our counsel at Hunter Taubman Fischer & Li LLC, Joan Wu, Esq. at jwu@htflawyers.com or 212-530-2208.

    Very truly yours,

    /s/ Ruilin Xu

    Ruilin Xu

Chief Executive Officer

cc: Hunter Taubman Fischer & Li LLC

3